Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Director departure

Nexvet Biopharma plc (NVET) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/13/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/10/2017 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
08/08/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/31/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/31/2017 RW Form RW - Registration Withdrawal Request:
07/31/2017 8-K Quarterly results
07/31/2017 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
07/28/2017 GN Nexvet Biopharma plc ("Nexvet") Rule 17(d) Announcement
07/10/2017 8-K Form 8-K - Current report:
07/10/2017 GN Nexvet Biopharma plc ("Nexvet") Rule 17(c) Announcement
07/05/2017 8-K Form 8-K - Current report
07/05/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/05/2017 GN Nexvet Biopharma plc ("Nexvet") Rule 2.10 Announcement
07/03/2017 GN Nexvet Biopharma plc ("Nexvet") Supplement Announcement
06/30/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/19/2017 8-K Form 8-K - Current report
06/19/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/19/2017 GN Nexvet Biopharma plc ("Nexvet") Rule 2.10 Announcement
06/16/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/16/2017 8-K Form 8-K - Current report
06/16/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/16/2017 GN Nexvet Biopharma plc ("Nexvet") Rule 15 Announcement
06/14/2017 8-K Form 8-K - Current report
06/14/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/14/2017 GN Nexvet Biopharma plc ("Nexvet") Rule 2.10 Announcement
06/09/2017 CT ORDER Form CT ORDER - Confidential treatment order
06/07/2017 8-K Form 8-K - Current report
06/07/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/07/2017 GN Nexvet Biopharma plc ("Nexvet") Rule 17(b) Announcement
06/05/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/02/2017 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
06/02/2017 GN Nexvet Biopharma plc ("Nexvet") Rule 17 Announcement
06/02/2017 8-K Form 8-K - Current report
06/02/2017 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy